201Tl SPECT as an indicator for early prediction of therapeutic effects in patients with non-small cell lung cancer

Annals of Nuclear Medicine

Volumn 12, Issue 6, 1998, Pages 355-362

  Suga, Kazuyoshi ^a   Kume, Norihiko ^b   Nishigauchi, Kazuya ^b   Ogasawara, Nobuhiko ^b   Hara, Akiko ^b   Miura, Gouji ^b   Matsumoto, Tsuneo ^b   Matsunaga, Naofumi ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Lung cancer; Radiation therapy; Single photon emission computed tomography (SPECT); Thallium 201 chloride

Indexed keywords

THALLIUM 201; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM CHLORIDE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SCINTISCANNING; MALE; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADJUVANT CHEMOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; LUNG; LUNG TUMOR; MIDDLE AGED; RETROSPECTIVE STUDY; SCINTISCANNING;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THALLIUM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032216728     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164925     Document Type: Article

References (26)

1. Canellos GP. Residual mass may not be residual disease. J Clin Oncol 6: 931-931, 1988.
2. Rozental JM, Levine RL, Mehta MP, Kinsella TS, Levin AB, Algan O, et al. Early changes in tumor metabolism after treatment: the effect of stereotactic radiotherapy. Int J Radiol Oncol Biol Phys 20: 1053-1060, 1991.
3. 201Tl scintigraphy in the evaluation of lung lesions and post-therapy follow-up of primary lung carcinoma. Nucl Med Commun 14: 446-453, 1993.
4. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 technetium MDP in the evaluation of chemotherapeutic response. J Nucl Med 31: 567-572, 1990.
5. Harris EW, Rakow JI, Weiner M, Agress H Jr. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease. J Nucl Med 34: 1326-1330, 1993.
6. Shimizu M, Seto H, Kageyama M, Wu YW, Morijiri M, Watanabe N, et al. Assessment of treatment response in irradiated lung cancer by sequential thallium-201 SPECT: Comparison with tumor volume change and survival time. Diagnostic Radiology 14: 7-12, 1996.
7. Namba R, Narabayashi I, Matsui R, Sueyoshi K, Nakata Y, Tabuchi K, et al. Evaluation of Tl-201 SPECT for monitoring the treatment of pulmonary and mediastinal tumors. Ann Nucl Med 9: 65-74, 1995.
8. 201Tl SPECT in the evaluation of treatment effect for primary lung cancer. KAKU IGAKU (Jpn J Nucl Med) 32: 1333-1340, 1995. (in Japanese)
9. Kostakoglu L, Ranicek DM, Divgi CR, Botet J, Healy J, Larson SM, et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med 22: 1232-1237, 1995.
10. Lorberboym M, Mandell LR, Mosesson RE, Germano I, Lou W, DaCosta M, et al. The role of thallium-201 uptake and retention in intracranial tumors after radiotherapy. J Nucl Med 38: 223-226, 1997.
11. 201Tl-chloride scintigraphy for monitoring radiotherapeutic effects. Nucl Med Commun 15: 128-139, 1994.
12. 201Tl-chloride uptake ratios in differentiating benign from malignant lesions: recommendations for ratio calculation and interpretation. Nucl Med Commun 16: 145-149, 1995.
13. 201Tl accumulation on single photon emission computed tomography in benign and malignant thoracic lesions. Nucl Med Commun 14: 1071-1078, 1993.
14. Tonami N, Shuke N, Yokoyama K, Seki H, Takayama T, Kimura S, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 30: 997-1004, 1989.
15. Takekawa H, Itoh K, Abe S, Ogura S, Isobe H, Furudate M, et al. Thallium-201 uptake, histological differentiation and Na-K ATPase in lung adenocarcinoma. J Nucl Med 37: 955-958, 1996.
16. Takekawa H, Itoh K, Abe S, Ogura S, Isobe H, Sukou N, et al. Retention index of thallium-201 single photon emission computed tomography (SPECT) as an indicator for metastasis in adenocarcinoma of the lung. Br J Cancer 70: 315-318, 1994.
17. Takekawa H, Takaoka K, Tsukamoto E, Kanegae K, Miller F, Kawakami Y. Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung cancer. Cancer 80: 198-203, 1997.
18. Ochi H, Sawa H, Fukuda T, Inoue Y, Nakajima H, Masuda Y, et al. Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules. Cancer 50: 236-240, 1982.
19. El-Desouki M. Tl-201 thyroid imaging in differentiating benign from malignant thyroid nodules. Clin Nucl Med 16: 425-430, 1991.
20. Kume N, Suga K, Nishigauchi K, Kawamura M, Matsunaga N. Relationships between thallium-201 uptake and tumor proliferative ability in thyroid nodules. Eur J Nucl Med 23: 376-382, 1996.
21. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N, Tateno M, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 34: 2085-2089, 1993.
22. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Nuerosurg 71: 342-346, 1989.
23. Lin J, Leung WT, Ho SKW, Ho KC, Kumta SM, Metreweli C, et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 22: 553-555, 1995.
24. 201Tl a reliable agent in tumor imaging? Nucl Med Commun 17: 805-809, 1996.
25. 201Tl uptake in tumors. Eur J Nucl Med 15: 376-379, 1989.
26. Kaplan WD, Takvorian T, Mornis JH, Rumbaugh CL, Connly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 28: 47-52, 1987.